H1N1VACCINATION.US

“It is our hope that ZADAXIN will ultimately provide the enhancement benefits to H1N1 vaccines for patients with compromised or weakened immune systems. If this study continues to show positive data, we may also explore the potential of … All patients who did not achieve an antibody titer of at least 1:40 on day 21 received a second H1N1 vaccination on that day. Dosing regimens were based on preclinical results obtained in ferret and mouse models conducted in Europe and …

Read more here:
SciClone And Sigma-Tau Announce Additional Positive Results In …

Overall, our determination that intravenous peramivir may be effective in treating hospitalized patients with 2009 H1N1 influenza was based on the drug’s demonstrated activity as a neuraminidase inhibitor and the treatment benefit observed in … (Accessed November 2, 2009, at http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM187799.pdf.) « Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand …

Read the original:
Emergency Use Authorization of Peramivir for Treatment of 2009 …

provide patients with adequate informed consent including a succinct summary of the current information needed to make an informed decision about H1N1 vaccination . This should include information about the risks of the vaccine , …

See more here:
What does informed consent mean when it comes to swine flu …